Day

July 2, 2019

2
Jul
2019

Cancer Survivor and Cancer Drug Developer: Laura Shawver on The Long Run

Today’s guest on The Long Run is Laura Shawver. Laura is the CEO of San Diego-based Synthorx. This company, based on research from The Scripps Research Institute, is using a couple of newly invented base pairs of DNA to make site-specific modifications on fully expressed proteins. This capability, Synthorx believes, could be put to practical use to craft ideal drug-like...
Read More